Advertisement
Screener

CEPHALON INC Patents: Active

CEPHALON INC Active Patents

31 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2019-06-20: Application 16471616; Invention ANTIBODIES THAT SPECIFICALLY BIND TO HUMAN IL-15 AND USES THEREOF; Applicant Cephalon, Inc.; Status Patented Case.
  • 2019-06-12: Application 16468960; Invention ANTIBODY VARIANTS TRANSMIGRATING THE BLOOD-BRAIN BARRIER AND USES THEREOF; Applicant Cephalon, Inc.; Status Patented Case.
  • 2019-01-09: Application 16316451; Invention PHARMACEUTICAL PRODRUGS AND METHODS OF THEIR PREPARATION AND USE; Applicant CEPHALON, INC.; Status Patented Case.
  • 2018-10-26: Application 16172368; Invention Fused Bicyclic 2,4-Diaminopyrimidine Derivative as a Dual ALK and FAK Inhibitor; Applicant Cephalon, Inc.; Status Patented Case.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2019-06-2016471616ANTIBODIES THAT SPECIFICALLY BIND TO HUMAN IL-15 AND USES THEREOFCephalon, Inc.Patented Case2022-03-0811267883US20200270339A1
David Jose Simon LAINE
Matthew POLLARD
Anthony Gerard DOYLE
Lynn Dorothy POULTON
Adam William CLARKE
Australia
Australia
Australia
Australia
Australia
SEHARASEYON, JEGATHEESAN
2019-06-1216468960ANTIBODY VARIANTS TRANSMIGRATING THE BLOOD-BRAIN BARRIER AND USES THEREOFCephalon, Inc.
National Research Council of Canada
Patented Case2021-02-0210906973US20200095316A1
Danica Stanimirovic
Traian Sulea
Kristin Kemmerich
David Wilson
Jennifer Stratton
Matthew Pollard
Adam Clarke
Canada
Canada
Canada
United States
United States
Australia
Australia
MACFARLANE, STACEY NEE
2019-01-0916316451PHARMACEUTICAL PRODRUGS AND METHODS OF THEIR PREPARATION AND USECEPHALON, INC.Patented Case2021-07-2711071789US20190240348A1
Anthony S. DRAGER
Paritosh WATTAMWAR
United States
United States
BAKSHI, PANCHAM
2018-10-2616172368Fused Bicyclic 2,4-Diaminopyrimidine Derivative as a Dual ALK and FAK InhibitorCephalon, Inc.Patented Case2020-04-2810632119US20190328735A1
Shawn P. Allwein
Laurent Courvoisier
Martin J. Jacobs
Gregory R. Ott
United States
United States
United States
United States
PAGANO, ALEXANDER R
2018-10-1816164509Antibodies That Specifically Bind To TL1A and Methods of Treating Respiratory Tract DiseasesCephalon, Inc.Patented Case2022-01-1111220549US20190106486A1
Lynn Dorothy Poulton
Matthew Pollard
Anthony G. Doyle
Bridget A. Cooksey
Vanya Pande
Adam W. Clarke
Australia
Australia
Australia
Australia
Australia
Australia
KAUFMAN, CLAIRE M
2018-08-2416112016TREATMENT STRATEGY FOR NON-RESPONDERS TO 100MG SUBCUTANEOUS MEPOLIZUMABCephalon, Inc.Patented Case2022-01-1811224653US20190062421A1
Parameswaran Nair
Manali Mukherjee
Canada
Canada
HOWARD, ZACHARY C
2018-07-1716037560NOVEL SOLID FORMS OF BENDAMUSTINE HYDROCHLORIDECephalon, Inc.Patented Case2019-12-3110517852US20190015390A1
Martin Ian Cooper
Laurent D. Courvoisier
Mark Eddleston
Robert E. McKean
United Kingdom
United States
United Kingdom
United States
HEYER, DENNIS
2018-06-2116014778CATION EXCHANGE CHROMATOGRAPHY WASH BUFFERCephalon, Inc.Patented Case2022-08-3011426706US20190046956A1
Lu WANG
Albert Kao
Zhaoqing Zhang
Mi Jin
Tianyi Zhou
United States
United States
United States
United States
United States
PEO, KARA M
2017-12-2015848090Anti-IL-5 AntibodiesCephalon, Inc.Patented Case2021-09-0711111292US20180186873A1
Mark Terence Liddament
Anthony Doyle
Adam Clarke
David Jose Simon Laine
Bridget Ann Cooksey
Australia
Australia
Australia
Australia
Australia
SEHARASEYON, JEGATHEESAN
2017-10-1315783289Use of Reslizumab to Treat Moderate to Severe Eosinophilic AsthmaCephalon, Inc.Patented Case2020-03-0310577414US20180030131A1
Christopher Obrien
James Zangrilli
Tushar Shah
Guy Brusselle
United States
United States
United States
Belgium
HAMUD, FOZIA M
2017-07-2515659093AFFINITY CHROMATOGRAPHY WASH BUFFERCephalon, Inc.Patented Case2020-06-2310688412US20180021696A1
Lu WANG
Tianyi ZHOU
Zhaoqing ZHANG
Mi JIN
United States
United States
United States
United States
ROGERS, JAMES L
2017-06-2015537954METHODS FOR PREPARING FUSED BICYCLIC 2, 4-DIAMINOPYRIMIDINE DERIVATIVESCEPHALON, INC.Patented Case2019-04-1610259794US20170369451A1
Shawn P. ALLWEIN
Roger P. BAKALE
Dale R. MOWREY
Daniel E. PETRILLO
Sander KLUWER
United States
United States
United States
United States
Netherlands
LEESER, ERICH A
2017-03-0715451960FUSED BICYCLIC 2,4-DIAMINOPYRIMIDINE DERIVATIVE AS A DUAL ALK AND FAK INHIBITORCephalon, Inc.Patented Case2018-10-3010111872US20170173017A1
Shawn P. Allwein
Laurent Courvoisier (deceased)
Martin J. Jacobs
Gregory R. Ott
United States
United States
United States
United States
PAGANO, ALEXANDER R
2017-02-0615425421NANOPARTICULATE AND MACROPARTICULATE FORMULATIONSCephalon, Inc.Patented Case2019-02-1210201506US20170143640A1
Peter D. Brown
Anthony S. Drager
United States
United States
SASAN, ARADHANA
2016-11-2315359777NOVEL SOLID FORMS OF BENDAMUSTINE HYDROCHLORIDECephalon, Inc.Patented Case2018-08-0710039750US20170071913A1
Martin Ian Cooper
Laurent D. Courvoisier (Deceased)
Mark Eddleston
Robert E. McKean
United Kingdom
United States
United Kingdom
United States
HEYER, DENNIS
2016-09-1615267213ANTIBODIES THAT SPECIFICALLY BIND TO TL1ACephalon, Inc.Patented Case2018-11-2710138296US20170081400A1
Lynn Dorothy Poulton
Matthew Pollard
Anthony G. Doyle
Bridget Ann Cooksey
Vanya Pande
Adam William Clarke
Australia
Australia
Australia
Australia
Australia
Australia
KAUFMAN, CLAIRE M
2016-06-17151857101,4-SUBSTITUTED PIPERIDINE DERIVATIVESCephalon, Inc.Patented Case2018-02-279902696US20160368874A1
Nadine C. Becknell
Reddeppa Reddy Dandu
Bruce D. Dorsey
Dimitar B. Gotchev
Robert L. Hudkins
Linda Weinberg
Craig A. Zificsak
Allison L. Zulli
United States
United States
United States
United States
United States
United States
United States
United States
DAVIS, BRIAN J
2016-02-1715045523Novel Solid Forms Of Bendamustine HydrochlorideCephalon, Inc.Patented Case2017-01-039533955US20160159748A1
Martin Ian Cooper
Laurent D. Courvoisier
Mark Eddleston
Robert E. McKean
United Kingdom
United States
United Kingdom
United States
HEYER, DENNIS
2015-09-0314772540NANOPARTICULATE AND MACROPARTICULATE FORMULATIONSCEPHALON, INC.Patented Case2017-03-219598377US20160002173A1
Peter D. BROWN
Anthony S. DRAGER
United States
United States
SASAN, ARADHANA
2015-08-1214824750Fused Bicyclic 2,4-diaminopyrimidine Derivative as a Dual ALK and FAK InhibitorCephalon, Inc.Patented Case2016-05-179339502US20150374693A1
Shawn P. Allwein
Laurent Courvoisier
Martin J. Jacobs
Gregory R. Ott
United States
United States
United States
United States
PAGANO, ALEXANDER R
2014-09-0214474928Fused Bicyclic 2,4-diaminopyrimidine Derivative as a Dual ALK and FAK InhibitorCephalon, Inc.Patented Case2015-09-159132128US20150011561A1
Shawn P. Allwein
Laurent Courvoisier
Martin J. Jacobs
Gregory R. Ott
United States
United States
United States
United States
PAGANO, ALEXANDER R
2014-03-0714200738Novel Solid Forms Of Bendamustine HydrochlorideCephalon, Inc.Patented Case2014-11-118883836US20140187598A1
Martin Ian Cooper
Laurent D. Courvoisier
Mark Eddleston
Robert E. McKean
United Kingdom
United States
United Kingdom
United States
HEYER, DENNIS
2013-08-1913969724BENDAMUSTINE PHARMACEUTICAL COMPOSITIONSCephalon, Inc.Patented Case2014-07-298791270US20130338205A1
Jason Edward Brittain
Joe Craig Franklin
United States
United States
SOROUSH, ALI
2013-07-2413949346Proteasome Inhibitors And Methods Of Using The SameCephalon, Inc.Patented Case2016-01-129233115US20140088042A1
Raffaella Bernardini
Alberto Bernareggi
Paolo G. Cassara
Sankar Chatterjee
Germano D'Arasmo
Sergio De Munari
Edmondo Ferretti
Mohamed Iqbal
Ernesto Menta
Patricia A. Messina McLaughlin
Ambrogio Oliva
Italy
Italy
Italy
United States
Italy
Italy
Italy
United States
Italy
United States
Italy
LEE, ANDREW P
2013-06-1813920153PREPARATION AND USES OF 1,2,4-TRIAZOLO [1,5A] PYRIDINE DERIVATIVESCephalon, Inc.Patented Case2014-01-218633173US20130296312A1
Matthew A. Curry
Bruce D. Dorsey
Benjamin J. Dugan
Diane E. Gingrich
Eugen F. Mesaros
Karen L. Milkiewicz
United States
United States
United States
United States
United States
United States
ROZOF, TIMOTHY R
2013-06-0613911465TREATMENT OF CHRONIC INFLAMMATION WITH A 1,2,4-TRIAZOLO [1,5A] PYRIDINE DERIVATIVECephalon, Inc.Patented Case2015-05-199034876US20130267535A1
Pawel T. Dobrzanski
Matthew M. Seavey
United States
United States
RAMACHANDRAN, UMAMAHESWARI
2013-06-0613911447JANUS KINASE 2 (JAK2) INHIBITOR FOR THE TREATMENT OF LUPUSCephalon, Inc.Patented Case2015-05-059023853US20140024655A1
Pawel T. Dobrzanski
Matthew M. Seavey
United States
United States
CLAYTOR, DEIRDRE RENEE
2013-05-0113874575NOVEL SOLID FORMS OF BENDAMUSTINE HYDROCHLORIDECEPHALON, INC.Patented Case2014-03-118669279US20130245086A1
Martin Ian Cooper
Laurent D. Courvoisier
Mark Eddleston
Robert E. McKean
United Kingdom
United States
United Kingdom
United States
HEYER, DENNIS
2012-12-1913719409Bendamustine Pharmaceutical CompositionsCephalon, Inc.Patented Case2014-11-258895756US20130131131A1
Jason Edward Brittain
Joe Craig Franklin
United States
United States
SOROUSH, ALI
2012-10-1813654898Bendamustine Pharmaceutical CompositionsCEPHALON, INC.Patented Case2013-06-118461350US20130041003A1
Jason Edward Brittain
Joe Craig Franklin
United States
United States
SOROUSH, ALI
2012-10-1813654765TUMOR NECROSIS FACTOR INHIBITORSCEPHALON, INC.
THE TRUSTEES OF THE UNIVERSITY OF PENNSYVANIA
Patented Case2014-07-018765810US20130072562A1
MARK I. GREENE
RAMACHANDRAN MURALI
XIN CHENG
RAPHAEL OTTENBRITE
YINGXIN XIAO
United States
United States
United States
United States
United States
YOO, SUN JAE